Skip to content

Twist Bioscience Corporation TWST Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

10x Genomics, Inc. logo
10x Genomics, Inc.TXG
-$1.95M-135%
Danaher logo
DanaherDHR
Illumina logo
IlluminaILMN
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
AbbVie logo
AbbVieABBV
Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%
Enterprise value$5.44B+30.4%
P/S13.3×+0.7×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's increase (decrease) in prepaid expense and other assets?
Twist Bioscience Corporation (TWST) reported increase (decrease) in prepaid expense and other assets of $11.13M in Q1 2026.
How has Twist Bioscience Corporation's increase (decrease) in prepaid expense and other assets changed year-over-year?
Twist Bioscience Corporation's increase (decrease) in prepaid expense and other assets increased by 1082.0% year-over-year, from -$1.13M to $11.13M.
What is the long-term trend for Twist Bioscience Corporation's increase (decrease) in prepaid expense and other assets?
Over 2 years (2022 to 2025), Twist Bioscience Corporation's increase (decrease) in prepaid expense and other assets has grown at a 16.6% compound annual growth rate (CAGR), from $2.74M to $3.72M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.